<?xml version="1.0" encoding="UTF-8"?>
<ref id="b113-ir-2019-09155">
 <label>113</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vigan√≤</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Serra</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Casella</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Grossi</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Lampertico</surname>
    <given-names>P</given-names>
   </name>
  </person-group>
  <article-title>Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders</article-title>
  <source>Expert Opin Biol Ther</source>
  <year>2016</year>
  <volume>16</volume>
  <fpage>917</fpage>
  <lpage>926</lpage>
  <pub-id pub-id-type="pmid">27088278</pub-id>
 </element-citation>
</ref>
